The regulation mechanism of cartilage destruction m osteoarthritis
The regulation mechanism of cartilage destruction m osteoarthritis
批准号:
14571386
负责人:
MATSUMOTO Tomoko
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
软骨基质合成和降解之间的不平衡导致关节软骨的破坏。为了了解骨关节炎软骨破坏的调节机制,我们研究了胰岛素样生长因子(IGF)- 1、地塞米松和氨基美辛对软骨组织分解代谢因子白介素(IL)-1β的作用。我们进行了软骨细胞的单层或三维培养。用ELISA法检测IL-6和基质金属蛋白酶(MMP)-3、-9、-13的浓度,并测定IL-6和基质金属蛋白酶(MMP)-3、-9、-13的浓度。提取细胞层总RNA, RT - PCR检测聚集蛋白、II型胶原、IL-6和mmp -3,9,13 mRNA的表达。在IL-β存在或不存在的情况下,IGF-I诱导聚集蛋白和胶原II mRNA的表达。il - 1 β增加了IL-6和MMPs在蛋白和mRNA水平上的表达。地塞米松和吲哚美辛可抑制IL-Iβ的这些作用,而IGF-I则不能。这些结果提示软骨破坏的调控可能存在不同的机制。
英文摘要
Imbalances between synthesis and degradation of cartilage matrix lead the destruction of articular cartilage. To know the regulation mechanism of cartilage destruction in osteoarthritis, we have examined the effects of insulin-like growth factor (IGF)-I, dexamethasone, and mdomethacin on the action of interleukin (IL)-1β, which is the catabolic factor for cartilage tissue. We performed monolayer or three dimensional culture of chondrocytes. After adding the IL-I β with or without IGF-I, dexamethasone or indomethacin, the concentration of IL-6 and matrix metalloptroteinase (MMP)-3,-9,-13 in the culture medium was measured by ELISA. Further, total RNA was extracted from the cell layer, and the expression of aggrecan, collagen II, IL-6, and MMP-3,9,13 mRNA was measured by RT PCR.IGF-I induced the expression of aggrecan and collagen II mRNA both in the presence or absence of IL-β. IL-I β increased the expression of IL-6 and MMPs in the protein and mRNA levels. These effects of IL-Iβ was inhibited by dexamethasone and indomethacin but not by IGF-I. These results suggest that different mechanism may exist in the regulation of cartilage destruction.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Matsumoto, T. et al.: "Inappropriate serum levels of IGF-I and IGPBP-3 in patients with rheumatoid arthritis"Rheumatology (Oxford). 41. 352-353 (2002)
Matsumoto, T. 等人:“类风湿性关节炎患者中 IGF-I 和 IGPBP-3 的血清水平不适当”《风湿病学》(牛津)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Iioka T, et al.: "P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart 1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain."J Bone Miner Res. 18. 1419-1429 (2003)
Iioka T 等人:“P300/CBP 通过乙酰化与同源结构域相邻的保守赖氨酸残基,充当软骨同源蛋白-1 (Cart 1)(配对样同源蛋白)的共激活剂。”J Bone Miner Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tsukazaki T et al.: "Functional domains of paired-like homeoprotein Cart1 and the relationship between dimerzation and transcription activity."Gene Cells. 7. 1135-1147 (2002)
Tsukazaki T 等人:“配对样同源蛋白 Cart1 的功能域以及二聚化与转录活性之间的关系。”基因细胞。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsumoto T, et al.: "Transient osteoporosis of the Talus followed by migration to the tibia."Modem Rheumatology. 30. 371-375 (2003)
Matsumoto T 等人:“距骨短暂骨质疏松症,随后迁移至胫骨。”现代风湿病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Taniguchi T, et al.: "Changes of serum levels of osteocalcin, alkaline phosphatase, IGF-I and IGF-binding protein-3 during fracture healing"Injury. 34. 477-479 (2003)
Taniguchi T 等人:“骨折愈合过程中骨钙素、碱性磷酸酶、IGF-I 和 IGF-结合蛋白-3 血清水平的变化”损伤。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Pathology and treatment for osteoarthritis-efficient use of endogenous insulin-like growth factor-1
-
批准号:17591582
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:MATSUMOTO Tomoko
-
依托单位:
The role of IGF-I and IGF-binding proteins in osteoarthritis
-
批准号:12671424
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:MATSUMOTO Tomoko
-
依托单位:
Regulation mechanism of nsulin-like growth factor-binding proteins producion in osteoarthritis.
-
批准号:09671503
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1997
-
负责人:MATSUMOTO Tomoko
-
依托单位:
Signal transduction of TGF-b in rat articular chondrocytes
-
批准号:07671598
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:MATSUMOTO Tomoko
-
依托单位:
海外基金